MedTrace Logo

Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery

NCT00419185 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2007-01-08

No results posted yet for this study

Summary

To evaluate the anatomical and visual outcomes after vitrectomy and internal limiting membrane (ILM) peeling with indocyanine green (ICG) or trypan blue (TB) for idiopathic macular hole repair in a prospective randomized trial.

Conditions

  • Idiopathic Macular Hole

Interventions

PROCEDURE

Delamination of the Internal limiting membrane

Sponsors & Collaborators

  • University of Luebeck

    lead OTHER

Principal Investigators

  • Hans M Hoerauf, Prof. · Eye Clinic, University Schleswig Holstein, Campus Lübeck

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Completion
2005-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00419185 on ClinicalTrials.gov